Several studies have identified some gene mutations associated with Ca2+ regulatory which contributed to cardiac hypertrophy, including phospholamban (PLN), ryanodine receptor 2 (RYR2) and junctophilin 2 (JPH2).37 The gene discussed is PLN; the disease is cardiac hypertrophy.